CX Institutional’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
5,725
+1,137
+25% +$69.7K 0.01% 643
2026
Q1
$299K Sell
4,588
-5,349
-54% -$391K 0.01% 606
2025
Q4
$800K Buy
9,937
+593
+6% +$47.7K 0.02% 317
2025
Q3
$767K Buy
9,344
+80
+0.9% +$6.93K 0.02% 341
2025
Q2
$845K Buy
9,264
+35
+0.4% +$3.13K 0.03% 288
2025
Q1
$844K Buy
+9,229
New +$806K 0.03% 297
2023
Q1
Sell
-17,249
Closed -$1.57M 499
2022
Q4
$1.57M Buy
17,249
+625
+4% +$53.2K 0.1% 215
2022
Q3
$1.32M Sell
16,624
-292
-2% -$24.7K 0.09% 226
2022
Q2
$1.41M Sell
16,916
-620
-4% -$51.1K 0.11% 216
2022
Q1
$1.44M Buy
+17,536
New +$1.37M 0.12% 190
2020
Q3
Sell
-15
Closed -$1K 880
2020
Q2
$1K Sell
15
-25
-63% -$1.54K ﹤0.01% 791
2020
Q1
$2K Hold
40
﹤0.01% 659
2019
Q4
$3K Buy
+40
New +$2.72K ﹤0.01% 621
2019
Q2
Sell
-40
Closed -$2K 958
2019
Q1
$2K Hold
40
﹤0.01% 681
2018
Q4
$2K Hold
40
﹤0.01% 449
2018
Q3
$3K Hold
40
﹤0.01% 309
2018
Q2
$3K Buy
+40
New +$2.69K ﹤0.01% 289

Other funds holding DOX

CX Institutional's DOX Position: Q2 2026 in Review

CX Institutional increased its Amdocs (DOX) stake by 25% in Q2 2026, buying an estimated $69.7K and bringing the position to 5,725 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #643.

CX Institutional first reported a position in DOX in Q2 2018 and has held it in 17 quarters since. The position peaked at $1.57M in Q4 2022. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • CX Institutional held 5,725 shares of Amdocs worth $289K as of Q2 2026.
  • CX Institutional bought 1,137 Amdocs shares in Q2 2026, an estimated $69.7K.
  • Amdocs made up 0.01% of CX Institutional's portfolio in Q2 2026, its #643 holding.
  • CX Institutional first reported a position in Amdocs in Q2 2018 and has held it in 17 quarters since.
  • CX Institutional's Amdocs position peaked at $1.57M in Q4 2022.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.